Meet the Teams
Cystech wants to provide reliable, non-invasive methods to detect and monitor the progression of bladder cancer using urine biomarkers. Cystech's long term goal is to develop biomarkers that will eventually be used as potential drug targets or in diagnostic technologies. Cystech is led by pharmacy student My Ngo (pictured).
Dapken aims to develop solutions that provide personalized medicine. BevaDx is a blood-based test that enables doctors to determine which cancer patients will benefit from Bevacizumab treatment using a patented biomarker. With BevaDx, we envision a treatment paradigm where only the right patient receives Bevacizumab at the right time. Dapken's team members include pharmacy students Fahim Faruque (pictured), Chuka Udeze, Kevin Loh, and Natalie Park.
Therapy X is a drug platform for chronic illnesses that allows for the indefinite production of a biological therapeutic in appropriate quantities and at appropriate times after a small number of administrations. This would eliminate the patients' need to take their medicine daily or weekly. Inducent Therapeutics is led by graduate student Christian Kinney (pictured).
Stock-it Pocket's goal is to ensure that healthcare providers have the right equipment at the right time, reducing errors and stress while increasing time for direct patient care. Stock-it Pocket's team members include nursing students Katherine Tuttle (pictured), Aaron Callahan, Lindsay McMahon, Julia Baca, medical student Kevin Fan, Mechanical Design Engineer Miranda Marks, and Marketing Specialist Evan Heim.
TheraSol wants to treat cancer metastasis in triple-negative breast cancer (TNBC) patients using plant-derived proteins. Our first product would comprise a therapeutic as an IV bolus and oral dosage form that employs an isolated compound found in taro extract as the active pharmaceutical ingredient. TheraSol's team members include graduate student Raqeeb Jamil, pharmacy students Sebastian Bilitza and Teddy Dunning, medical student Aurasch Moaven, and lawyer Viqar Hussain.
Urban Algae is a biotech company focused on providing the public with toxin-free dietary algal supplements while revitalizing city spaces by fitting them with microalgal green roofs. Based in Baltimore, MD, Urban Algae works closely with IMET, a hub for biotechnology in the Mid-Atlantic States. Urban Algae's team members include marine estuarine environmental science students Kelsey Abernathy and Dan Fucich.